Explore the full directors' dealings record of JENOPTIK Aktiengesellschaft, a listed issuer based in Germany. Shares trade on DE DE, under the supervision of BaFin. Operating in the Technology sector, JENOPTIK Aktiengesellschaft has logged 1 public disclosures. Market capitalisation: €1.3bn. The latest transaction was filed on 19 May 2025 — Buy. Among the most active insiders: Havranek-Kosicek, Dr. Prisca. The full history is openly available.
1 of 1 declaration
JENOPTIK Aktiengesellschaft (ISIN: DE000A2NB601, ticker: JEN.DE) is a German technology group listed on Xetra/Frankfurt (DAX/MDAX/SDAX) and headquartered in Jena, Germany. The company is rooted in a long optical tradition in Jena and its modern corporate history begins in 1990, when JENOPTIK Carl Zeiss Jena GmbH was founded; JENOPTIK GmbH followed in 1991, JENOPTIK AG has existed since 1996, and the company was listed in Frankfurt in 1998. ([jenoptik.com](https://www.jenoptik.com/about-jenoptik/chronik)) Jenoptik is best described as a photonics-focused industrial technology company. Its business model is centered on high-precision optical and micro-optical products, systems, and process technologies sold mainly in B2B and B2G markets. The group’s main growth fields are semiconductor technology, biophotonics / medical technology, metrology and production solutions, and smart mobility. In operational terms, this translates into optical and micro-optical assemblies, precision components, imaging and lighting solutions, measurement technologies, and traffic/smart-mobility systems. Jenoptik’s annual report also highlights its exposure to key end markets such as semiconductors & electronics, life science & medical technology, and smart mobility. ([jenoptik.com](https://www.jenoptik.com/-/media/websitedocuments/ir/berichte-und-tabellen/2024/online-gb/english/jenoptik-annual-report-2024.pdf)) From a competitive standpoint, Jenoptik occupies specialized niches where technical know-how, customer-specific engineering and integration capabilities matter more than scale alone. This supports relatively high entry barriers and allows the group to position itself as an enabler technology provider. Management states that the transformation toward a global photonics company is largely complete and that the portfolio is now concentrated on core photonics growth areas. Jenoptik is represented in many countries worldwide, with direct presence in 18 countries, and its products are manufactured mainly in Germany, Switzerland, the US and China. Jena remains the strategic center of gravity, especially for Advanced Photonic Solutions. ([jenoptik.com](https://www.jenoptik.com/-/media/websitedocuments/ir/berichte-und-tabellen/2024/online-gb/english/jenoptik-annual-report-2024.pdf)) Recent developments have been material. On May 6, 2025, Jenoptik officially inaugurated a new fab in Dresden, described as the company’s largest single investment in recent history, expanding capacity for micro-optics and high-precision sensors used in high-performance chips and AI-related applications. In its first-quarter 2025 communication, the company said business was affected by a challenging market environment but stressed the strength of its financial and balance-sheet position. In June 2025, Jenoptik showcased new photonics solutions at Laser World of Photonics in Munich, including systems for solar-cell processing and endoscopic surgery. ([jenoptik.us](https://www.jenoptik.us/news/press-releases/2025/05/06/fab-opening-in-dresden)) For investors, Jenoptik offers exposure to structural growth themes such as semiconductors, medical technology and industrial measurement, while remaining sensitive to the semiconductor cycle and broader industrial demand. The combination of German engineering depth, a strong R&D base, and a broad international footprint makes the stock a quality industrial technology name with cyclical characteristics. ([jenoptik.com](https://www.jenoptik.com/-/media/websitedocuments/ir/berichte-und-tabellen/2024/online-gb/english/jenoptik-group-management-report-2024.pdf))